View photos Nevertheless, the company’s shares are trading up in the pre-market trading. Regeneron’s stock has lost 27.2% in the last six months compared with the industry’s 11.5% decline. The company reported earnings of $4.67 per …
Even after the drop, Regeneron shares are far from cheap, but those who still see …
"But the stock has also gotten a heck of a lot cheaper ... One of the first stocks …
CNBC15d
Regeneron Pharmaceuticals jumped 6.2% to $306.94 ... Nvidia reported solid quarterly results, but the chipmaker's stock shed some of its recent gains, …
Regeneron Pharmaceuticals jumped 6.2 percent to $306.94 and ... Natural gas slipped a penny to $2.80 per 1,000 cubic feet. European stock indexes finished …
Shares of Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) created a high-water mark around three and a half years ago that's still 51% above recent prices. The drugs it outlicensed to its big pharma partner, Sanofi (NYSE: SNY), …